HUP0101710A2 - Mátrix-protein kompozíciók sebgyógyulás elősegítésére - Google Patents

Mátrix-protein kompozíciók sebgyógyulás elősegítésére

Info

Publication number
HUP0101710A2
HUP0101710A2 HU0101710A HUP0101710A HUP0101710A2 HU P0101710 A2 HUP0101710 A2 HU P0101710A2 HU 0101710 A HU0101710 A HU 0101710A HU P0101710 A HUP0101710 A HU P0101710A HU P0101710 A2 HUP0101710 A2 HU P0101710A2
Authority
HU
Hungary
Prior art keywords
wound healing
matrix protein
protein compositions
enamel material
active enamel
Prior art date
Application number
HU0101710A
Other languages
English (en)
Inventor
Christer Andersson
Stina Gestrelius
Tomas Hammargren
Lars Hammarström
Petter Lyngstadaas
Ivan Slaby
Original Assignee
Biora Bioex Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biora Bioex Ab filed Critical Biora Bioex Ab
Publication of HUP0101710A2 publication Critical patent/HUP0101710A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Abstract

A találmány aktív zománcanyag-készítmény alkalmazására vonatkozik,éspedig olyan gyógyszerkészítmények vagy kozmetikai készítményekelőállítására, amelyek sebek gyógyítására, sebgyógyulás elősegítésére,lágy szövetek regenerálására és kijavítására, továbbá fertőzések ésgyulladások megelőzésére és kezelésére szolgálnak. Az aktívzománcanyag növésben levő fogakból nyerhető. Ó
HU0101710A 1998-02-27 1999-02-26 Mátrix-protein kompozíciók sebgyógyulás elősegítésére HUP0101710A2 (hu)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK27098 1998-02-27
US8155198P 1998-04-13 1998-04-13
DKPA199801328 1998-10-16
PCT/IB1999/000337 WO1999043344A2 (en) 1998-02-27 1999-02-26 Matrix protein compositions for wound healing

Publications (1)

Publication Number Publication Date
HUP0101710A2 true HUP0101710A2 (hu) 2001-09-28

Family

ID=27220558

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101710A HUP0101710A2 (hu) 1998-02-27 1999-02-26 Mátrix-protein kompozíciók sebgyógyulás elősegítésére

Country Status (19)

Country Link
EP (2) EP1153610B1 (hu)
JP (2) JP5024866B2 (hu)
KR (1) KR20010041408A (hu)
CN (1) CN1248734C (hu)
AT (2) ATE247483T1 (hu)
AU (1) AU740468B2 (hu)
BR (1) BR9908182A (hu)
CA (2) CA2322215C (hu)
DE (2) DE69902234T2 (hu)
DK (2) DK1153610T3 (hu)
ES (2) ES2204804T3 (hu)
HK (1) HK1030880A1 (hu)
HU (1) HUP0101710A2 (hu)
IL (1) IL137869A0 (hu)
IS (1) IS5591A (hu)
NO (1) NO20004282L (hu)
PL (1) PL202536B1 (hu)
SK (1) SK12362000A3 (hu)
WO (1) WO1999043344A2 (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030096740A1 (en) 1999-03-10 2003-05-22 Lars Hammarstrom Matrix protein compositions for induction of apoptosis
US7304030B2 (en) 2000-06-20 2007-12-04 Biora Ab Matrix protein composition for dentin regeneration
WO2001097834A1 (en) * 2000-06-20 2001-12-27 Biora Ab Matrix protein compositions for dentin regeneration
EP1361905B8 (en) * 2001-02-23 2007-12-12 Institut Straumann Ag Matrix protein compositions for guided connective tissue growth
US7033611B2 (en) 2001-02-23 2006-04-25 Biora Bioex Ab Matrix protein compositions for guided connective tissue growth
KR100934411B1 (ko) 2001-09-14 2009-12-29 바이오라 바이오엑스 에이비 면역반응을 조절하기 위한 에나멜 기질 단백질 조성물
PL369029A1 (en) * 2001-09-14 2005-04-18 Biora Bioex Ab Enamel matrix protein compositions for modulating immune response
KR100450146B1 (ko) * 2002-02-19 2004-09-30 정필훈 발치된 치아로부터 치아 단백질의 추출방법과 그의이용방법
KR101123113B1 (ko) * 2002-07-29 2012-03-15 쎄라피콘 에스.알.엘. 코 펩티드 약학 제형
JP2004307454A (ja) * 2003-02-21 2004-11-04 Seikagaku Kogyo Co Ltd 生理活性ペプチド及びこれを含有する薬剤
EP2329832A1 (en) 2004-12-10 2011-06-08 Straumann Holding AG Protein formulation
EP1862170B1 (en) * 2004-12-10 2012-03-14 Straumann Holding AG Enamel formulation with amelogenin
SE0403014D0 (sv) 2004-12-10 2004-12-10 Straumann Holding Ag New protein formulation
US7771751B2 (en) 2005-08-31 2010-08-10 Abraxis Bioscience, Llc Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
WO2011051457A2 (en) * 2009-11-02 2011-05-05 Straumann Holding Ag Purified emd protein composition
WO2011073447A1 (en) * 2009-12-18 2011-06-23 Straumann Holding Ag Emd c-depleted
GB0922438D0 (en) 2009-12-22 2010-02-03 Ucl Business Plc Agents having tissue generative activity
US9789190B2 (en) 2010-10-15 2017-10-17 Straumann Holding Ag EMD formulation comprising PGA
US20120294898A1 (en) * 2011-05-19 2012-11-22 Warsaw Orthopedic, Inc. Injectable dbm for soft tissue repair
EP2687224A1 (en) * 2012-07-19 2014-01-22 Tissue Med Biosciences Forschungs- und Entwicklungsgesellschaft mbH Medicament for wound treatment
SE536581C2 (sv) * 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
CN112915281B (zh) * 2021-03-12 2022-12-16 臻叶生物科技有限公司 一种无抗凝剂的prp生物膜制备装置及方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE454480B (sv) * 1986-09-25 1988-05-09 Lars Hammarstrom Bindningsinducerande komposition
SE461313B (sv) * 1988-03-17 1990-02-05 Biora Ab Bindningsinducerande komposition
CN1196086A (zh) * 1995-07-13 1998-10-14 比奥拉公司 釉质基质相关多肽
JP4726296B2 (ja) * 1998-02-27 2011-07-20 インスティチュート ストローマン アーゲー 創傷治癒のためのマトリックスタンパク質組成物

Also Published As

Publication number Publication date
AU740468B2 (en) 2001-11-08
JP2007291115A (ja) 2007-11-08
ES2183510T3 (es) 2003-03-16
CN1248734C (zh) 2006-04-05
KR20010041408A (ko) 2001-05-15
CA2640994C (en) 2013-07-09
WO1999043344A3 (en) 1999-11-25
CN1297356A (zh) 2001-05-30
NO20004282D0 (no) 2000-08-25
EP1059934A2 (en) 2000-12-20
PL343375A1 (en) 2001-08-13
BR9908182A (pt) 2001-11-13
WO1999043344A2 (en) 1999-09-02
NO20004282L (no) 2000-10-27
IS5591A (is) 2000-08-18
PL202536B1 (pl) 2009-07-31
DK1059934T3 (da) 2002-11-11
CA2322215C (en) 2010-12-21
SK12362000A3 (sk) 2001-04-09
CA2322215A1 (en) 1999-09-02
DK1153610T3 (da) 2003-12-08
EP1059934B1 (en) 2002-07-24
DE69902234D1 (de) 2002-08-29
JP2011088927A (ja) 2011-05-06
JP5227428B2 (ja) 2013-07-03
AU2436899A (en) 1999-09-15
EP1153610A1 (en) 2001-11-14
DE69910622D1 (de) 2003-09-25
ATE220918T1 (de) 2002-08-15
JP5024866B2 (ja) 2012-09-12
IL137869A0 (en) 2001-10-31
CA2640994A1 (en) 1999-09-02
ATE247483T1 (de) 2003-09-15
DE69902234T2 (de) 2003-03-27
DE69910622T2 (de) 2004-06-17
ES2204804T3 (es) 2004-05-01
EP1153610B1 (en) 2003-08-20
HK1030880A1 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
HUP0101710A2 (hu) Mátrix-protein kompozíciók sebgyógyulás elősegítésére
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
BR9911071A (pt) Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépticos e/ou agentes promotores da cura de feridas no trato respiratório superior e/ou no ouvido
DE60138549D1 (de) Topische gel-abgabesysteme zur behandlung von hauterkrankungen
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
DK1227820T3 (da) Oligosaccharidaldonsyrer og topisk anvendelse deraf
MXPA03011622A (es) Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas.
EP0821969A3 (en) Medicinal Composition comprising TCF-II
HUP0203321A2 (hu) (6-Metoxi-2-naftil)-ecetsav prodrug készítmények gyulladás kezelésére
ATE405276T1 (de) Pharmazeutische gel-zusammensetzung
HUP0204180A2 (hu) Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére
EP1361905B8 (en) Matrix protein compositions for guided connective tissue growth
RU94027755A (ru) Материал для заполнения послеоперационных костных полостей
PT1232173E (pt) Derivados do acido fusidico
WO2005041852A3 (en) Keratin gel and the types 2, 4 and 6 of collagens of frog protein
UA42335A (uk) Спосіб лікування гнійних ран
LT2002105A (en) Novel use of siberian fir oil